Warning Plans for Smokeless Tobacco Products

ICR 202410-0910-010

OMB: 0910-0671

Federal Form Document

Forms and Documents
Document
Name
Status
Justification for No Material/Nonsubstantive Change
2024-10-25
Supporting Statement A
2022-10-18
IC Document Collections
ICR Details
0910-0671 202410-0910-010
Received in OIRA 202204-0910-006
HHS/FDA CTP
Warning Plans for Smokeless Tobacco Products
No material or nonsubstantive change to a currently approved collection   No
Regular 10/25/2024
  Requested Previously Approved
12/31/2025 12/31/2025
5 5
180 180
0 0

Section 3 of the Comprehensive Smokeless Tobacco Health Education Act of 1986 (the Smokeless Tobacco Act), requires, among other things, that all smokeless tobacco product packages and advertisements bear one of four required warning statements. This information collection--the submission to FDA of warning plans for smokeless tobacco products--is statutorily mandated. Section (b)(3)(A) of 15 U.S.C. 4402 requires that the warnings be displayed on packaging and advertising for each brand of smokeless tobacco “in accordance with a plan submitted by the tobacco product manufacturer, importer, distributor, or retailer” to, and approved by, FDA. The warning plans will be reviewed by FDA to determine whether the companies' plans for the equal distribution and display of warning statements on packaging and the quarterly rotation of warning statements in advertising for each brand requires, among other things, that all smokeless tobacco product packages and advertisements bear one of four required warning statements.

PL: Pub.L. 113 - 31 3 Name of Law: Tobacco Control Act
   US Code: 15 USC 4402 Name of Law: Comprehensive Smokeless Tobacco Health Education Act of 1986
  
None

Not associated with rulemaking

  87 FR 27644 05/09/2022
87 FR 63075 10/18/2022
Yes

1
IC Title Form No. Form Name
Submission of rotational warning plans for health warning label statements

  Total Request Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 5 5 0 0 0 0
Annual Time Burden (Hours) 180 180 0 0 0 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
No
No
The total estimated burden for this information collection is 180 burden hours, and 5 annual responses. After receiving the initial influx of original warnings plans, FDA does not expect to receive as many original warning plans annually.

$58,753
No
    Yes
    No
No
No
No
No
Jonna Capezzuto 301 796-3794 jonnalynn.capezzuto@fda.hhs.gov

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
10/25/2024


© 2024 OMB.report | Privacy Policy